E1B 55 kDa early functions p53 tumor suppressor Normal human cells It is well established that the human subgroup C adenovirus type 5 (Ad5) E1B 55 kDa protein can regulate the activity and concentration of the cellular tumor suppressor, p53. However, the contribution(s) of these functions of the E1B protein to viral reproduction remains unclear. To investigate this issue, we examined properties of p53 in normal human cells infected by E1B mutant viruses that display defective entry into the late phase or viral late mRNA export. The steady-state concentrations of p53 were significantly higher in cells infected by the E1B 55 kDa null mutant Hr6 or three mutants carrying small insertions in the E1B 55 kDa protein coding sequence than in Ad5-infected cells. Nevertheless, none of the mutants induced apoptosis in infected cells. Rather, the localization of p53 to E1B containing nuclear sites observed during infection by Ad5 was prevented by mutations that impair interaction of the E1B protein with p53 and/or with the E4 Orf6 protein. These results indicate that the E1B protein fulfills an early function that correlates efficient entry into the late phase with the localization of E1B and p53 in the nucleus of Ad5-infected normal human cells.
Introduction
The human subgroup C adenoviral E1A, E1B and E4 early genes encode proteins that exhibit transforming activity because they disrupt host cell processes that regulate cell proliferation (Jones, 1990) . The same gene products are also responsible for establishing appropriate conditions in the infected cell for efficient viral DNA synthesis and production of viral progeny (Berk, 2006) . During the early phase of productive adenoviral infection, the E1A gene products induce accumulation of the cellular tumor suppressor p53, and apoptosis (Debbas and White, 1993; Lowe and Ruley, 1993; Zhang et al., 2004) . However, the E1B 19 and 55 kDa proteins can counter the cytotoxic effects of increased p53 concentrations (Cuconati et al., 2002; White, 2001) . The E1B 55 kDa protein binds to the aminoterminus of p53, tethering a repressor domain that inhibits transcription from promoters that contain p53 target sequences Berk, 1998, 1999; Yew et al., 1994) . Suppression of p53-dependent transcription has also been described for the E4 Orf6 protein, which can also bind to p53 (Dobner et al., 1996; Nevels et al., 1997) . Moreover, the E1B 55 kDa and E4 Orf6 proteins form a complex that can associate with cellular proteins to form an infected cell-specific, cullin5-containing E3 ubiquitin ligase that polyubiquitinylates and stimulates proteasomal degradation of p53 (Harada et al., 2002; Querido et al., 2001; Sarnow et al., 1984; Woo and Berk, 2007) .
In infected cell nuclei, the E1B 55 kDa and E4 Orf6 proteins colocalize to the peripheral zones of specific nuclear microenvironments where viral DNA replication, transcription of viral late genes and the initial posttranscriptional processing of viral late mRNAs take place (Aspegren et al., 1998; Bridge et al., 1995; Ornelles and Shenk, 1991; Pombo et al., 1994; Puvion-Dutilleul et al., 1992) . Mutations that reduce binding of the E1B 55 kDa (E1B) to the E4 Orf6 protein result in altered localization of E1B, and inefficient export of viral late mRNAs (Gonzalez and Flint, 2002; Ornelles and Shenk, 1991; Rubenwolf et al., 1997) , correlating efficient viral late mRNA export with the organization of infected cell nuclei.
Replication of mutants null for production of the E1B protein is temperature dependent, cell cycle restricted, and varies with the identity of the cell used as host (reviewed in Dix et al., 2001; Goodrum and Ornelles, 1997 , 1999 Harada and Berk, 1999; Ho et al., 1982) . While the first two properties have been ascribed to inefficient late mRNA export and late protein synthesis in HeLa and other transformed human cell lines (Goodrum and Ornelles, 1998; Harada and Berk, 1999; Ho et al., 1982; Leppard and Shenk, 1989; Royds et al., 2006; Shen et al., 2001; Williams et al., 1986) , the molecular mechanisms that are responsible for selective replication in specific cell types are not fully understood (Bischoff et al., 1996; Dix et al., 2001; Edwards et al., 2002; Hann and Balmain, 2003; Harada and Berk, 1999; Rothmann et al., 1998; Turnell et al., 1999) . Indeed, although considerable effort has been devoted to the study and development of viruses that can selectively replicate in, and kill tumor cells efficiently (Dobbelstein, 2004; Everts and van der Poel, 2005; Lichtenstein and Wold, 2004; O'Shea, 2005) , the basis for selective replication of E1B 55 kDa null mutants in transformed cells has not been elucidated. As the E1B protein can inactivate p53, it was initially hypothesized that these mutants would not replicate efficiently in the presence of wild-type p53 (Bischoff et al., 1996) . One such mutant, ONYX-015, initially called dl1520 (Barker and Berk, 1987) , has shown promising results in early clinical trials as an oncolytic agent (O'Shea, 2005 ) (reviewed in McCormick, 2003 . Nevertheless selective replication of ONYX-015 does not correlate with the p53 status of the cells used as host (Cherubini, et al., 2006; Goodrum and Ornelles, 1998; Harada and Berk, 1999; Rothmann et al., 1998; Turnell et al., 1999) . Furthermore, it has been reported that p53 may be required for efficient viral replication (Hall et al., 1998; Royds et al., 2006) . The p53 tumor suppressor is known to act as a master regulator of cell cycle progression and apoptosis in response to DNA damage and other types of stress (reviewed in Gostissa et al., 2003; Harris, 2005) . Its activities are governed by a variety of mechanisms that include regulated synthesis and translation of p53 mRNA, and post-translational modifications of the protein (reviewed in Oren, 1999) . The roles of p53 in induction of apoptosis or cell cycle arrest in response to genotoxic and other types of stress are well established, and much has been learnt about the mechanisms by which the activities of p53 are prevented by viral proteins in transformed cells (reviewed in Harris, 2005) . However, the functions of p53, and of the mechanisms by which the E1B protein blocks the accumulation or activity of this cellular protein during productive infection by adenoviruses, are not fully understood. Most studies to investigate the effects of Ad5 infection on p53 in productively infected cells have used established cell lines that either do not contain wild-type p53 or harbor other abnormal genotypic traits (Bischoff et al., 1996; Ornelles, 1997, 1998; Hall et al., 1998; Harada and Berk, 1999; Heise et al., 1997; Hobom and Dobbelstein, 2004; Rothmann et al., 1998; Steegenga et al., 1998 ) (reviewed in Dix et al., 2001; Dobbelstein, 2004) . We previously reported that infection of HFF with E1B mutants (H224, Hr6) that either do not express E1B or synthesize an E1B that is impaired for p53 binding resulted in inefficient DNA replication, implicating an early function of the E1B protein that is independent of selective viral late mRNA export and that could correlate with p53 binding. To address this issue, we have performed experiments designed to examine the impact of the interplay between the E1B 55 kDa, E4 Orf6 and p53 proteins on regulation of p53 in the context of a productive adenovirus infection of primary human cells.
Results

Effects of Ad5 and E1B mutant virus infection on the accumulation of the p53 protein
As discussed in the Introduction, the E1B 55 kDa protein can both associate with the cellular p53 tumor suppressor to repress p53-dependent transcription and, in conjunction with the viral E4 Orf6 protein, induce p53 degradation. Although these activities are required for E1B-dependent transformation, their contributions to productive adenoviral replication are not well understood. We recently observed that infection of normal human cells with the E1B 55 kDa null mutant Hr6, or an insertion mutant that affects binding of the E1B to p53 (H224) display defective viral DNA synthesis (Gonzalez et al., 2006) . We therefore wished to determine whether such defects might be a consequence of effects of the p53 protein, and first examined the steady-state concentrations of this cellular protein in Ad5 and Hr6-infected cells. Soluble extracts of infected HFFs were prepared and analyzed by immunoblotting as described in the Materials and methods section. Ad5 infection induced a reduction in the low concentration of p53 detected in HFFs, but not until 30 h pi, that is, late in infection (Fig. 1a) . As anticipated, significantly higher concentration of the cellular protein accumulated in Hr6-infected cells.
We also examined p53 concentration in cells infected with several previously characterized mutants carrying small insertions in the E1B coding sequence . The A143 mutation impairs binding of the E1B to the E4 Orf6 protein , and induces a severe defect in export of viral late mRNA in HFFs (Gonzalez et al., 2006) . The H224 mutation results in inhibition of viral DNA synthesis in HFFs, and reduced interaction of the E1B protein with both the E4 Orf6 and p53 proteins (Gonzalez et al., 2006; Yew et al., 1990) . The H354 insertion results in lower binding to the cellular E1B-AP5 protein (Gabler et al., 1998; Kao et al., 1990) , which has recently been reported to interact with the p53 protein (Barral et al., 2005) . A higher concentration of p53 was observed in cells infected by all the E1B mutants than detected in Ad5 infected cells (Fig. 1b) , indicating that degradation of p53 was impaired by each of the mutations, as well as by the absence of the E1B protein in Hr6-infected cells. This effect of the mutations on accumulation of p53 was significantly more pronounced late in infection.
The E1B 55 kDa protein is not required to protect HFFs against induction of apoptosis
The accumulation of the cellular p53 protein in HFFs infected by the E1B mutant viruses ( Fig. 1 ) could result in induction of apoptosis (see Introduction), which might contribute to inefficient viral replication. To investigate this possibility, apoptosis was examined in HFFs infected by Ad5 and the mutants described in the previous section. In these experiments, we used several different methods to assess induction of apoptosis, including FACS analysis of infected cells stained with fluorescent annexin V and propidium iodide and assays for cleavage of poly (ADP-ribose) polymerase (Parp).
Analysis of phosphatidylserine exposure in infected cells by FACS showed relatively small increases in the number of annexin V positive cells in Ad5-infected cells when compared to mock (from 8% to 14%) or in the E1B mutants-infected cells relative to Ad5 (from 14% to 22%), despite considerably higher intracellular concentrations of p53 in the E1B mutants-infected cells (Fig. 2) . Furthermore, virtually no specific cleavage of Parp could be detected in HFFs infected by Hr6 (or Ad5), although efficient cleavage (i.e. induction of apoptosis) was observed in control cells treated with TNF-α and cycloheximide (Fig. 2b) . We have also observed no significant activation of caspase 3 in any infected cells, using an activated caspase specific antibody (not shown). The failure to detect a significant increase in apoptotic cells in Hr6-infected cells by very different assays indicates that this cellular response is efficiently inhibited in the absence of the E1B 55 kDa protein, and in cells that contain high concentrations of p53.
Binding of E1B 55 kDa to E4 Orf6 or p53 leads to altered intracellular localization of p53 in HFFs
One of the mechanisms of p53 activation requires relocalization of p53 by Pml proteins to specific intranuclear sites, termed nuclear bodies (NB) or nuclear domains 10 (ND10), a process that is essential for both transcriptional regulation of p53-responsive genes and activation of the apoptotic program (Gostissa et al., 2003; Pearson, 2001; Takahashi et al., 2004) . To assess the role of the E1B 55 kDa protein in the subcellular reorganization of p53 during adenovirus infection, we analyzed the effects of infection with Ad5 and the E1B mutants on p53 localization. As previously reported, the kinetics of Ad5 replication in HFF cells are delayed and entry into the late phase occurs at approximately 24 h after infection (Gonzalez et al., 2006) . HFFs grown to approximately 90% confluence were initially infected with Ad5, the E1B-null mutant Hr6 or mock-infected, and the intracellular distributions of E1B and p53 were examined by immunofluorescence, at times after infection that correspond to the early and late phases (20 h and 32 h, respectively), as described in the Materials and methods section. The E1B protein distribution in Ad5 infected HFFs was similar to that described previously in HeLa cells (Ornelles and Shenk, 1991) , where it was present in the nucleus of most cells as diffuse homogeneous staining and in numerous small specks and ring-like structures. However, two types of ring-like structures that differed in size and number were apparent in HFFs by 20 h after infection: small ring-like structures similar to the peripheral zones of replication centers at which E1B, DBP and E4 Orf6 have been previously localized (Gonzalez and Flint, 2002; Ornelles and Shenk, 1991) , and a smaller number, of larger ring-like structures (Fig. 3 , panels a and c). By the late phase, at 32 h after infection, a more pronounced localization to both types of rings was observed in most cells (Fig. 3 , panels d and f). As expected, no E1B was detected in cells infected with Hr6, or that were mock-infected (Fig. 4) .
As the intracellular localization of p53 in Ad5-infected HFFs has not been reported, we initially examined its distribution in mock-infected cells (Fig. 4) . The protein was distributed throughout the cytoplasm in a fine reticular structure, similar to the cytoskeletal fibrillar actin network that has been suggested for the cytoplasmic localization of p53 (Katsumoto et al., 1995; Laín et al., 1999; Metcalfe et al., 1999) . Within the nucleus, denser staining was seen, and appeared as a mesh or interconnected network.
Significant alterations in p53 localization were observed in Hr6-infected cells, that is, in the absence of the E1B 55 kDa protein. Hr6 infection caused a sharp decrease in the concentration of cytoplasmic p53 by 20 h after infection, when most of the protein localized to the nucleus. The nuclear concentration of p53 remained high at 32 h after infection (Fig. 4) . These observations indicate that infection of HFFs by Ad5 induces alterations in the intracellular localization of p53 that are independent of the E1B 55 kDa protein. The cytoplasmic population of p53 also decreased by 20 h after Ad5 infection, but in contrast to Hr6-infected cells, by 32 h the cytopathic effects were advanced, and a cytoplasmic p53-associated signal could be seen in disorganized, bleb-like structures (Fig. 3, panel e) .
Furthermore, by 20 h after Ad5 infection, the p53 signal was concentrated inside and around spherical nuclear structures, showing a higher density at their periphery, where it displayed a partial but clear colocalization with the rings formed by the E1B protein (Fig. 3,   Fig. 4 . Nuclear accumulation of p53 in HFFs infected with the E1B-null mutant Hr6. Cells were infected with Hr6 at 30 PFU/cell or mock-infected, and processed for immunofluorescence with the 421 and 2A6 MAbs as described in Materials and methods. The arrows indicate nuclear structures devoid of p53 in mock-infected cells and in cells infected with Hr6 at 32 h. Cells were analyzed using a 63× water immersion objective. For closer inspection images were amplified 2× as indicated. Fig. 3 . Intracellular localization of E1B 55 kDa and p53 proteins in Ad-infected HFFs. The intracellular distribution of E1B and p53 was analyzed by immunofluorescence and confocal microscopy at 20 h and 32 h after infection. Monoclonal antibodies 2A6 and 421 were directly labeled with Alexa-488 and Alexa-594, respectively, and used simultaneously. The small and large ring-like structures described in the text are indicated by white arrowheads and arrows, respectively. Cells were analyzed using a 63× water immersion objective. For closer inspection images were magnified 2×. panels a-c). The accumulation of the p53 protein in these structures was more pronounced at 32 h after Ad5 infection, when the nuclear organization of the protein was clearly associated with that of E1B, as the large rings formed by E1B were the sites of highest p53 accumulation: protein present inside these globular structures was most concentrated at the periphery, coinciding with the highest E1B protein concentration (Fig. 3, panels d-f) . A similar pattern of distribution has been observed for p53 in Ad5-infected HFF cells using a different anti-p53 antibody (MAb 1801), indicating that the signal observed is specific for p53 (Supplementary Fig. 1 ). These data indicate, that although the initial re-distribution of p53 to the cell nucleus induced by Ad5 infection does not depend on the E1B 55 kDa protein, the relocalization of p53 to both types of ring-like structures is induced only when this viral protein is made. Furthermore the p53 protein colocalizes with the E1B protein within the nucleus during both the early and late phases of infection.
We next examined the effects of the E1B insertion mutants on the intracellular locations of the viral and the p53 proteins. By 20 h after infection with the A143 or H224 mutants, most of the E1B protein was present in nuclei, where its distribution was more diffuse than in Ad5- Fig. 5 . Effect of E1B mutations, on the subcellular localization of p53. The localization of E1B and p53 was analyzed in HFFs infected with the E1B mutants at 20 h and 32 h after infection as described in Materials and methods: A143, panels a-f; H224, panels g-l; H354, panels m-r. The small and large ring-like structures described in the text are indicated by white arrowheads and arrows, respectively. infected cells, with few cells showing small circular structures (Fig. 5 , panels b and h). Moreover, although the larger ring-like structures were present in some cells, they did not appear as clearly defined as in Ad5-infected cells. The p53 protein was associated with the large dotlike structures in some cells, but its distribution appeared diffuse and homogeneous in the nucleus of A143-infected cells (compare Figs. 3 to 5, panels a-c), and not as well defined, nor as obviously interconnected, in the nucleus of H224-infected cells, as in Ad5-infected cells (Fig. 5, panels g-i) . Moreover, by 32 h after infection fewer cells displayed colocalization of E1B and p53 in ring-like structures (Fig. 5,  panels d-f and j-l) . In contrast to A143 and H224, the altered E1B protein synthesized in H354-infected HFFs displayed a localization pattern in ring-like structures similar to that of the wild-type protein (Fig. 5, panels m-o) . Furthermore, only cells infected by H354 displayed the temporal alterations in the distribution of p53 characteristic of Ad5-infected cells (Figs. 5m-r) . For example, formation of structures with the p53 protein concentrated in globules was observed only in cells infected by Ad5 or H354. These data indicate that the relocalization of p53 induced by Ad5 infection of HFFs requires binding of the E1B 55 kDa protein to both the E4 Orf6 and p53 proteins.
Discussion
Adenovirus mutants that either do not produce the E1B 55 kDa protein or synthesize altered proteins display defects in late phase functions such as inefficient viral late mRNA export (see the Introduction). We recently found that this viral protein also fulfills an important early function during infection of normal human cells, as viral DNA synthesis is less efficient in cells infected by Hr6 than in Ad5-infected cells (Gonzalez et al., 2006) .
Inefficient viral DNA synthesis cannot be correlated with increased accumulation of p53 in infected cells: the greatest increases in p53 concentration were observed during the late phase in cells infected by the mutant viruses. Furthermore, all the mutations examined here resulted in substantial accumulation of p53 (Fig. 1) , even though viral DNA synthesis is defective only in cells infected by Hr6 and H224 (Gonzalez et al., 2006) . The A143 mutation inhibits binding of the E1B 55 kDa to the E4 Orf6 protein , whereas the H224 insertion results in less efficient interaction of the E1B protein with p53 and E4 Orf6 (Gabler et al., 1998; Kao et al., 1990; Rubenwolf et al., 1997) . The interaction of E1B with both E4 Orf6 and p53 is required for targeting of p53 for degradation by a cullin5-containing ubiquitin ligase (Harada et al., 2002; Liu et al., 2005; Querido et al., 2001 ). This property accounts for the accumulation of p53 in cells infected by A143 and H224. An unexpected observation was that the H354 mutant, which directs the synthesis of an E1B protein that interacts efficiently with E4 Orf6 and p53, also failed to induce p53 degradation. As the H354 insertion decreased binding of the viral protein to E1B-AP5 (Gabler et al., 1998) , it is possible that p53 degradation also requires efficient binding of E1B to AP5, which has been reported to associate with p53 (Barral et al., 2005) .
Accumulation of p53 can induce apoptosis, and it has been generally assumed that inhibition of p53-dependent activation of pro-apoptotic signals by the E1B 55 kDa protein facilitates adenovirus replication (Debbas and White, 1993; White and Cipriani, 1990) . However, none of the E1B mutations resulted in levels of phosphatidylserine exposure or Parp cleavage that were significantly higher than those observed in Ad5-or mock-infected cells (Fig. 2) . We therefore conclude that they do not induce apoptosis, despite high intracellular concentration of p53 in all mutant virus-infected cells. This conclusion is consistent with the observation that high concentrations of p53 did not result in apoptosis in ONYX-015-infected small airway epithelial cells (O'Shea et al., 2004) . Moreover, we also observed that complete degradation of p53 is not attained in Ad5-infected HFFs, in agreement with previous reports (Royds et al., 2006; Yew and Berk, 1992) , indicating that regulation of the activity of p53 is likely to be achieved by additional processes.
The activities of p53 are controlled by multiple mechanisms, including various post-translational modifications, interactions with other proteins, and recruitment to different cellular compartments (see the Introduction). One important mechanism depends on the Pml proteins, which recruit p53 to NBs in response to a variety of stress stimuli (Pearson et al., 2000) , reviewed in (Fogal, et al., 2000; Gostissa et al., 2003; Guo et al., 2000) . Indeed, such post-translational modifications of p53 as acetylation, phosphorylation and deubiquitination are mediated by enzymes that are present in Pml-containingNBs including CBP/p300 (histone acetyl transferases), HIPK2 (a p53 kinase), and HAUSP (a p53 deubiquitinase). It has therefore been proposed that these structures act as mini-factories for p53 posttranslational modification, to which p53 is recruited in response to different forms of stress, and that localization of p53 to specific nuclear structures is essential for its function as a regulator of transcription and cell cycle arrest or apoptosis (reviewed in Bernardi, 2003; Gostissa et al., 2003) .
A characteristic feature of adenovirus-infected cells is the formation of infected cell-specific, nuclear structures with the concomitant relocalization of several cellular components. The E1A proteins, which bind to Rb and p300 to induce stabilization of p53 (Querido et al., 1997) , are found with the viral E4 Orf3 protein in ring-like and fibrous structures that contain cellular Pml proteins (Carvalho et al., 1995) . The E4 Orf3 protein induces reorganization of Pml to form these structures (Doucas et al., 1996; Hoppe et al., 2006; Leppard and Everett, 1999; Stracker et al., 2002) , and in Ad5-infected HFF the PML fibers appear to colocalize with p53 (unpublished observations). The E4 Orf3 is also required for relocalization of components of the cellular Mre11-Rad50-Nbs1 complex and efficient formation of viral DNA replication centers (Doucas et al., 1996; Evans and Hearing, 2005) . Binding of the E1B 55 kDa protein to E4 Orf3 and E4 Orf6 is needed for proper localization of E1B to DBP and E4 Orf6-containing replication centers (Gonzalez and Flint, 2002; Leppard and Everett, 1999; Lethbridge et al., 2003; Ornelles and Shenk, 1991) . We now demonstrate that the intracellular distribution of p53 is also altered following Ad5 infection. This protein accumulates in the nucleus of infected cells in the absence of the E1B protein (Fig. 4) . However, globular structures containing p53 are formed efficiently only in infected cells that contain an E1B 55 kDa protein that is able to bind to p53 and E4 Orf6, namely in . As these structures appear before initiation of viral DNA synthesis, we conclude that an early function of the E1B 55 kDa protein in normal host cells is relocalization of the p53 tumor suppressor.
It has been proposed that all the functions of the E1B 55 kDa protein depend on its ability to associate with, and activate, a high molecular weight ubiquitin protein ligase that assembles in aggresomes and induces proteasomal degradation of p53 and the Mre11 protein (Araujo et al., 2005; Liu et al., 2005; Woo and Berk, 2007) . A dominant negative derivative of cullin 5 inhibited such degradation, as well as induction of selective export of viral late mRNA (Woo and Berk, 2007) . In our experiments, we did not detect a perinuclear, E1B protein-containing structure characteristic of the aggresome in Ad5-infected HFFs. This failure is likely to be due to the severe cytopathic effects induced in HFFs at the late times after Ad5 infection that correspond to those at which aggresomes containing viral proteins can be detected in HeLa cells (Araujo et al., 2005) . It will therefore be of interest to determine whether this structure can be observed at later time points in primary cells infected at lower multiplicity. Nevertheless, we have identified an early function of the E1B 55 kDa protein that appears to be unrelated to formation of the infected cellspecific ubiquitin ligase complex: formation of this complex (Querido et al., 2001; Woo and Berk, 2007) , but not efficient viral DNA synthesis (Gonzalez et al., 2006) , requires binding of the E1B to the viral E4 Orf6 protein.
Materials and methods
Cells and viruses
293 and human foreskin fibroblast (HFF) cells were grown as monolayer cultures in Dulbecco's modified Eagle's medium supplemented with 5% and 10% fetal calf serum, respectively. The E1B mutant viruses A143, H224 and H354, which carry linker insertions in a hybrid Ad2/Ad5 E1B gene, were generously provided by A. Berk . The Ad5 mutant Hr6, which carries a frameshift mutation in the E1B 55 kDa coding sequence, was described previously (Harrison et al., 1977) . Ad5 (wild-type 300) and the E1B mutants were propagated in monolayers of HeLa and 293 cells, respectively. Viruses were titered by plaque assay on 293 cells as described (Williams, 1973) , and a multiplicity of infection of 30 PFU per cell was used in all experiments.
Steady-state concentrations of the cellular p53 protein HFF cells at approximately 75-90% confluence were infected with Ad5 or the E1B mutants at 30 PFU/cell. For immunoblotting, cells were harvested at the times after infection indicated, washed with phosphate-buffered saline (PBS), and extracted with 25 mM TrisHCl, pH 8.0, containing 50 mM NaCl, 0.5% (w/v) sodium deoxycholate, 0.5% (v/v) Nonidet P-40 (NP-40) and 1 mM phenylmethylsulfonyl fluoride for 30 min at 4°C. Cell debris was removed by centrifugation at 10,000 ×g at 4°C for 5 min. The extracts were analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and immunoblotting as described previously (Gonzalez and Flint, 2002) . The p53 protein was detected with the monoclonal antibody 421 (Harlow et al., 1981) ; an anti-tubulin MAb (Sigma) was used as internal control.
Apoptosis assays
To assay for phosphatidylserine exposure and membrane permeability to propidium iodide, the annexin V-FLUOS system (Roche) was used according to the manufacturer's protocol. HFFs mock-infected or infected with Ad5 or E1B mutants were harvested 16 h after infection by the addition of phosphate-buffered saline (PBS) containing 5 mM EDTA. After cells were detached from the plates, ice-cold PBS containing 10 mM CaCl 2 was added, and the cells were centrifuged at 200 ×g. The supernatant was discarded and cells were resuspended in HEPES buffer containing FITC coupled annexin V and propidium iodide and FITC positive cells were quantified by flow cytometry using a FACSCalibur System (Becton Dickinson). Results represent the average of at least two independent experiments, and all measurements were performed at least in duplicate. To assay for cleavage of poly (ADPribose) polymerase (Parp), HFFs were infected with Ad5 or Hr6, or mock-infected. At the times indicated cells were harvested, washed with PBS and incubated with 20 mM Tris-HCl, pH 7.5 containing 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.5% NP40, 2.5 mM sodium pyrophosphate, 1 mM β-glycerol phosphate, 1 mM Na 3 VO 4 , 1 mM PMSF, 2 μg/ml leupeptin, and 1 μg/ml antipain on ice for 20 min. Lysates were sonicated briefly, centrifuged at 12,000 ×g at 4°C for 10 min and analyzed by immunoblotting using anti-cleaved Parp (Asp214) 19F4 mouse monoclonal antibody (Cell Signaling). HFFs incubated with TNF (1 ng/ml) and cycloheximide (10 μg/ml) for 4 h were used as positive controls.
Immunofluorescence
HFFs grown on coverslips to approximately 90% confluence were mock-infected, or infected with Ad5 or E1B mutant viruses. At 20 and 32 h after infection (corresponding to early and late times of infection, respectively), the cells were processed for immunofluorescence as described previously (Gonzalez and Flint, 2002) . Treated cells were incubated simultaneously with purified anti-p53 421 IgG coupled to Alexa-Fluor 594, and purified anti-E1B 55 kDa 2A6 IgG coupled to Alexa-Flour 488 (Molecular Probes), both prepared and purified according to the manufacturer's protocol. The coverslips were mounted on glass slides in Aqua Polymount (Polysciences Inc.), and samples were examined by confocal microscopy as described previously (Gonzalez and Flint, 2002) . Images were organized using Adobe Photoshop 7.0.
